StockSelector.com
  Research, Select, & Monitor Thursday, July 20, 2017 8:36:57 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
United Therapeutics Corp.$131.25$1.29.99%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

United Therapeutics Corp. has an overall rank of 1397 out of 6904 stocks based on 10 positive rankings and 9 negative rankings.

Positive Rankings
Highest ROA
United Therapeutics rank is 68
Target Prices
The average analysts' target price is $213.00 for United Therapeutics using target prices set or adjusted within the past 90 days. Among companies with recent target prices and with the average above the current stock price, United Therapeutics is ranked 110.
Highest Cash Growth
United Therapeutics rank is 123
Top Industry Values
United Therapeutics rank is 169
Highest Net Margin
United Therapeutics rank is 171
Highest ROE
United Therapeutics rank is 204
Historic EPS Growth
United Therapeutics rank is 233
Debt-to-Equity
United Therapeutics rank is 549
Historic Revenue Growth
United Therapeutics rank is 770
Up EPS Surprise
United Therapeutics beat the consensus earnings estimate when it last reported quarterly earnings.
Negative Rankings
Negative EPS Growth
United Therapeutics rank is 67
Negative Revenue Estimate
United Therapeutics rank is 168
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, United Therapeutics is ranked 186.
High Put/Call
United Therapeutics has a high Put/Call ratio of 2.34 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, United Therapeutics is ranked 261.
High vPut/Call
United Therapeutics has a high Put/Call ratio of 3.11 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, United Therapeutics is ranked 346.
90 Day Loss
United Therapeutics rank is 838
10 Day Loss
United Therapeutics rank is 855
Price-to-Book
United Therapeutics rank is 1608
Price-to-Sales
United Therapeutics rank is 1672







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2017 StockSelector.com. All rights reserved.